 | • レポートコード：MRC2-11QY08607 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は子宮収縮剤のグローバル市場について調査・分析したレポートです。種類別（天然オキシトシン、合成オキシトシン誘導体）市場規模、用途別（中絶誘発不完全、不可避中絶、分娩後出血、陣痛誘発、陣痛停止）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別子宮収縮剤の競争状況、市場シェア ・世界の子宮収縮剤市場：種類別市場規模 2015年-2020年（天然オキシトシン、合成オキシトシン誘導体） ・世界の子宮収縮剤市場：種類別市場規模予測 2021年-2026年（天然オキシトシン、合成オキシトシン誘導体） ・世界の子宮収縮剤市場：用途別市場規模 2015年-2020年（中絶誘発不完全、不可避中絶、分娩後出血、陣痛誘発、陣痛停止） ・世界の子宮収縮剤市場：用途別市場規模予測 2021年-2026年（中絶誘発不完全、不可避中絶、分娩後出血、陣痛誘発、陣痛停止） ・北米の子宮収縮剤市場分析：米国、カナダ ・ヨーロッパの子宮収縮剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの子宮収縮剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の子宮収縮剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの子宮収縮剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Fresenius Kaci、Biofutura、Baxter、Pfizer、Ferring、Novartis、Teva ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Available under the brand name of Pitocin, the drug oxytocin, which is derived from the peptide of the same name, is commonly used on women during childbirth in order to induce contractions. This can not only increase labor speeds and reduce the time taken for childbirth, but can also cease bleeding after delivery. It is almost always administered to a patient by injecting it into their vein or muscle.
The post-partum haemorrhage segment is expected to register high Y-o-Y growth during the forecast period and is projected to remain the dominant segment during the forecast period.
Market Analysis and Insights: Global Oxytocic Pharmaceuticals Market
The global Oxytocic Pharmaceuticals market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Oxytocic Pharmaceuticals Scope and Market Size
Oxytocic Pharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oxytocic Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oxytocic Pharmaceuticals market is segmented into
Natural Oxytocin
Synthetic Oxytocin Derivative
Segment by Application, the Oxytocic Pharmaceuticals market is segmented into
Abortion Induced Incomplete
Inevitable Abortion
Post-partum Haemorrhage
Labour Induction
Labour Arrest
Regional and Country-level Analysis
The Oxytocic Pharmaceuticals market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oxytocic Pharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oxytocic Pharmaceuticals Market Share Analysis
Oxytocic Pharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oxytocic Pharmaceuticals business, the date to enter into the Oxytocic Pharmaceuticals market, Oxytocic Pharmaceuticals product introduction, recent developments, etc.
The major vendors covered:
Fresenius Kaci
Biofutura
Baxter
Pfizer
Ferring
Novartis
Teva
…
1 Study Coverage
1.1 Oxytocic Pharmaceuticals Product Introduction
1.2 Market Segments
1.3 Key Oxytocic Pharmaceuticals Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oxytocic Pharmaceuticals Market Size Growth Rate by Type
1.4.2 Natural Oxytocin
1.4.3 Synthetic Oxytocin Derivative
1.5 Market by Application
1.5.1 Global Oxytocic Pharmaceuticals Market Size Growth Rate by Application
1.5.2 Abortion Induced Incomplete
1.5.3 Inevitable Abortion
1.5.4 Post-partum Haemorrhage
1.5.5 Labour Induction
1.5.6 Labour Arrest
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Oxytocic Pharmaceuticals Market Size, Estimates and Forecasts
2.1.1 Global Oxytocic Pharmaceuticals Revenue 2015-2026
2.1.2 Global Oxytocic Pharmaceuticals Sales 2015-2026
2.2 Global Oxytocic Pharmaceuticals, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Oxytocic Pharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oxytocic Pharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oxytocic Pharmaceuticals Competitor Landscape by Players
3.1 Oxytocic Pharmaceuticals Sales by Manufacturers
3.1.1 Oxytocic Pharmaceuticals Sales by Manufacturers (2015-2020)
3.1.2 Oxytocic Pharmaceuticals Sales Market Share by Manufacturers (2015-2020)
3.2 Oxytocic Pharmaceuticals Revenue by Manufacturers
3.2.1 Oxytocic Pharmaceuticals Revenue by Manufacturers (2015-2020)
3.2.2 Oxytocic Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oxytocic Pharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oxytocic Pharmaceuticals Revenue in 2019
3.2.5 Global Oxytocic Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oxytocic Pharmaceuticals Price by Manufacturers
3.4 Oxytocic Pharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Oxytocic Pharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oxytocic Pharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into Oxytocic Pharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oxytocic Pharmaceuticals Market Size by Type (2015-2020)
4.1.1 Global Oxytocic Pharmaceuticals Sales by Type (2015-2020)
4.1.2 Global Oxytocic Pharmaceuticals Revenue by Type (2015-2020)
4.1.3 Oxytocic Pharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oxytocic Pharmaceuticals Market Size Forecast by Type (2021-2026)
4.2.1 Global Oxytocic Pharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global Oxytocic Pharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 Oxytocic Pharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oxytocic Pharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Oxytocic Pharmaceuticals Market Size by Application (2015-2020)
5.1.1 Global Oxytocic Pharmaceuticals Sales by Application (2015-2020)
5.1.2 Global Oxytocic Pharmaceuticals Revenue by Application (2015-2020)
5.1.3 Oxytocic Pharmaceuticals Price by Application (2015-2020)
5.2 Oxytocic Pharmaceuticals Market Size Forecast by Application (2021-2026)
5.2.1 Global Oxytocic Pharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global Oxytocic Pharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global Oxytocic Pharmaceuticals Price Forecast by Application (2021-2026)
6 North America
6.1 North America Oxytocic Pharmaceuticals by Country
6.1.1 North America Oxytocic Pharmaceuticals Sales by Country
6.1.2 North America Oxytocic Pharmaceuticals Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oxytocic Pharmaceuticals Market Facts & Figures by Type
6.3 North America Oxytocic Pharmaceuticals Market Facts & Figures by Application
7 Europe
7.1 Europe Oxytocic Pharmaceuticals by Country
7.1.1 Europe Oxytocic Pharmaceuticals Sales by Country
7.1.2 Europe Oxytocic Pharmaceuticals Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oxytocic Pharmaceuticals Market Facts & Figures by Type
7.3 Europe Oxytocic Pharmaceuticals Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Oxytocic Pharmaceuticals by Region
8.1.1 Asia Pacific Oxytocic Pharmaceuticals Sales by Region
8.1.2 Asia Pacific Oxytocic Pharmaceuticals Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oxytocic Pharmaceuticals Market Facts & Figures by Type
8.3 Asia Pacific Oxytocic Pharmaceuticals Market Facts & Figures by Application
9 Latin America
9.1 Latin America Oxytocic Pharmaceuticals by Country
9.1.1 Latin America Oxytocic Pharmaceuticals Sales by Country
9.1.2 Latin America Oxytocic Pharmaceuticals Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oxytocic Pharmaceuticals Market Facts & Figures by Type
9.3 Central & South America Oxytocic Pharmaceuticals Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Oxytocic Pharmaceuticals by Country
10.1.1 Middle East and Africa Oxytocic Pharmaceuticals Sales by Country
10.1.2 Middle East and Africa Oxytocic Pharmaceuticals Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oxytocic Pharmaceuticals Market Facts & Figures by Type
10.3 Middle East and Africa Oxytocic Pharmaceuticals Market Facts & Figures by Application
11 Company Profiles
11.1 Fresenius Kaci
11.1.1 Fresenius Kaci Corporation Information
11.1.2 Fresenius Kaci Description and Business Overview
11.1.3 Fresenius Kaci Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Fresenius Kaci Oxytocic Pharmaceuticals Products Offered
11.1.5 Fresenius Kaci Related Developments
11.2 Biofutura
11.2.1 Biofutura Corporation Information
11.2.2 Biofutura Description and Business Overview
11.2.3 Biofutura Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biofutura Oxytocic Pharmaceuticals Products Offered
11.2.5 Biofutura Related Developments
11.3 Baxter
11.3.1 Baxter Corporation Information
11.3.2 Baxter Description and Business Overview
11.3.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Baxter Oxytocic Pharmaceuticals Products Offered
11.3.5 Baxter Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Oxytocic Pharmaceuticals Products Offered
11.4.5 Pfizer Related Developments
11.5 Ferring
11.5.1 Ferring Corporation Information
11.5.2 Ferring Description and Business Overview
11.5.3 Ferring Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Ferring Oxytocic Pharmaceuticals Products Offered
11.5.5 Ferring Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Description and Business Overview
11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis Oxytocic Pharmaceuticals Products Offered
11.6.5 Novartis Related Developments
11.7 Teva
11.7.1 Teva Corporation Information
11.7.2 Teva Description and Business Overview
11.7.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teva Oxytocic Pharmaceuticals Products Offered
11.7.5 Teva Related Developments
11.1 Fresenius Kaci
11.1.1 Fresenius Kaci Corporation Information
11.1.2 Fresenius Kaci Description and Business Overview
11.1.3 Fresenius Kaci Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Fresenius Kaci Oxytocic Pharmaceuticals Products Offered
11.1.5 Fresenius Kaci Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Oxytocic Pharmaceuticals Market Estimates and Projections by Region
12.1.1 Global Oxytocic Pharmaceuticals Sales Forecast by Regions 2021-2026
12.1.2 Global Oxytocic Pharmaceuticals Revenue Forecast by Regions 2021-2026
12.2 North America Oxytocic Pharmaceuticals Market Size Forecast (2021-2026)
12.2.1 North America: Oxytocic Pharmaceuticals Sales Forecast (2021-2026)
12.2.2 North America: Oxytocic Pharmaceuticals Revenue Forecast (2021-2026)
12.2.3 North America: Oxytocic Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.3 Europe Oxytocic Pharmaceuticals Market Size Forecast (2021-2026)
12.3.1 Europe: Oxytocic Pharmaceuticals Sales Forecast (2021-2026)
12.3.2 Europe: Oxytocic Pharmaceuticals Revenue Forecast (2021-2026)
12.3.3 Europe: Oxytocic Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oxytocic Pharmaceuticals Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oxytocic Pharmaceuticals Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oxytocic Pharmaceuticals Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oxytocic Pharmaceuticals Market Size Forecast by Region (2021-2026)
12.5 Latin America Oxytocic Pharmaceuticals Market Size Forecast (2021-2026)
12.5.1 Latin America: Oxytocic Pharmaceuticals Sales Forecast (2021-2026)
12.5.2 Latin America: Oxytocic Pharmaceuticals Revenue Forecast (2021-2026)
12.5.3 Latin America: Oxytocic Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oxytocic Pharmaceuticals Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oxytocic Pharmaceuticals Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oxytocic Pharmaceuticals Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oxytocic Pharmaceuticals Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oxytocic Pharmaceuticals Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oxytocic Pharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Oxytocic Pharmaceuticals Market Segments
Table 2. Ranking of Global Top Oxytocic Pharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oxytocic Pharmaceuticals Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Natural Oxytocin
Table 5. Major Manufacturers of Synthetic Oxytocin Derivative
Table 6. Global Oxytocic Pharmaceuticals Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 7. Global Oxytocic Pharmaceuticals Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 8. Global Oxytocic Pharmaceuticals Sales by Regions 2015-2020 (K Pcs)
Table 9. Global Oxytocic Pharmaceuticals Sales Market Share by Regions (2015-2020)
Table 10. Global Oxytocic Pharmaceuticals Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Oxytocic Pharmaceuticals Sales by Manufacturers (2015-2020) (K Pcs)
Table 12. Global Oxytocic Pharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 13. Global Oxytocic Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Oxytocic Pharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxytocic Pharmaceuticals as of 2019)
Table 15. Oxytocic Pharmaceuticals Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Oxytocic Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Oxytocic Pharmaceuticals Price (2015-2020) (USD/Pcs)
Table 18. Oxytocic Pharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Oxytocic Pharmaceuticals Product Type
Table 20. Date of International Manufacturers Enter into Oxytocic Pharmaceuticals Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Oxytocic Pharmaceuticals Sales by Type (2015-2020) (K Pcs)
Table 23. Global Oxytocic Pharmaceuticals Sales Share by Type (2015-2020)
Table 24. Global Oxytocic Pharmaceuticals Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Oxytocic Pharmaceuticals Revenue Share by Type (2015-2020)
Table 26. Oxytocic Pharmaceuticals Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 27. Global Oxytocic Pharmaceuticals Sales by Application (2015-2020) (K Pcs)
Table 28. Global Oxytocic Pharmaceuticals Sales Share by Application (2015-2020)
Table 29. North America Oxytocic Pharmaceuticals Sales by Country (2015-2020) (K Pcs)
Table 30. North America Oxytocic Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 31. North America Oxytocic Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Oxytocic Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 33. North America Oxytocic Pharmaceuticals Sales by Type (2015-2020) (K Pcs)
Table 34. North America Oxytocic Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 35. North America Oxytocic Pharmaceuticals Sales by Application (2015-2020) (K Pcs)
Table 36. North America Oxytocic Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 37. Europe Oxytocic Pharmaceuticals Sales by Country (2015-2020) (K Pcs)
Table 38. Europe Oxytocic Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 39. Europe Oxytocic Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Oxytocic Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 41. Europe Oxytocic Pharmaceuticals Sales by Type (2015-2020) (K Pcs)
Table 42. Europe Oxytocic Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 43. Europe Oxytocic Pharmaceuticals Sales by Application (2015-2020) (K Pcs)
Table 44. Europe Oxytocic Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Oxytocic Pharmaceuticals Sales by Region (2015-2020) (K Pcs)
Table 46. Asia Pacific Oxytocic Pharmaceuticals Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Oxytocic Pharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Oxytocic Pharmaceuticals Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Oxytocic Pharmaceuticals Sales by Type (2015-2020) (K Pcs)
Table 50. Asia Pacific Oxytocic Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Oxytocic Pharmaceuticals Sales by Application (2015-2020) (K Pcs)
Table 52. Asia Pacific Oxytocic Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 53. Latin America Oxytocic Pharmaceuticals Sales by Country (2015-2020) (K Pcs)
Table 54. Latin America Oxytocic Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Oxytocic Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Oxytocic Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 57. Latin America Oxytocic Pharmaceuticals Sales by Type (2015-2020) (K Pcs)
Table 58. Latin America Oxytocic Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 59. Latin America Oxytocic Pharmaceuticals Sales by Application (2015-2020) (K Pcs)
Table 60. Latin America Oxytocic Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Oxytocic Pharmaceuticals Sales by Country (2015-2020) (K Pcs)
Table 62. Middle East and Africa Oxytocic Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Oxytocic Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Oxytocic Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Oxytocic Pharmaceuticals Sales by Type (2015-2020) (K Pcs)
Table 66. Middle East and Africa Oxytocic Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Oxytocic Pharmaceuticals Sales by Application (2015-2020) (K Pcs)
Table 68. Middle East and Africa Oxytocic Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 69. Fresenius Kaci Corporation Information
Table 70. Fresenius Kaci Description and Major Businesses
Table 71. Fresenius Kaci Oxytocic Pharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 72. Fresenius Kaci Product
Table 73. Fresenius Kaci Recent Development
Table 74. Biofutura Corporation Information
Table 75. Biofutura Description and Major Businesses
Table 76. Biofutura Oxytocic Pharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. Biofutura Product
Table 78. Biofutura Recent Development
Table 79. Baxter Corporation Information
Table 80. Baxter Description and Major Businesses
Table 81. Baxter Oxytocic Pharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Baxter Product
Table 83. Baxter Recent Development
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Major Businesses
Table 86. Pfizer Oxytocic Pharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Pfizer Product
Table 88. Pfizer Recent Development
Table 89. Ferring Corporation Information
Table 90. Ferring Description and Major Businesses
Table 91. Ferring Oxytocic Pharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Ferring Product
Table 93. Ferring Recent Development
Table 94. Novartis Corporation Information
Table 95. Novartis Description and Major Businesses
Table 96. Novartis Oxytocic Pharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Novartis Product
Table 98. Novartis Recent Development
Table 99. Teva Corporation Information
Table 100. Teva Description and Major Businesses
Table 101. Teva Oxytocic Pharmaceuticals Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Teva Product
Table 103. Teva Recent Development
Table 104. Global Oxytocic Pharmaceuticals Sales Forecast by Regions (2021-2026) (K Pcs)
Table 105. Global Oxytocic Pharmaceuticals Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Oxytocic Pharmaceuticals Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Oxytocic Pharmaceuticals Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Oxytocic Pharmaceuticals Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. North America: Oxytocic Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Oxytocic Pharmaceuticals Sales Forecast by Country (2021-2026) (K Pcs)
Table 111. Europe: Oxytocic Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Oxytocic Pharmaceuticals Sales Forecast by Region (2021-2026) (K Pcs)
Table 113. Asia Pacific: Oxytocic Pharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Oxytocic Pharmaceuticals Sales Forecast by Country (2021-2026) (K Pcs)
Table 115. Latin America: Oxytocic Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Oxytocic Pharmaceuticals Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. Middle East and Africa: Oxytocic Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Oxytocic Pharmaceuticals Players
Table 122. Oxytocic Pharmaceuticals Customers List
Table 123. Oxytocic Pharmaceuticals Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Oxytocic Pharmaceuticals Product Picture
Figure 2. Global Oxytocic Pharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Natural Oxytocin Product Picture
Figure 4. Synthetic Oxytocin Derivative Product Picture
Figure 5. Global Oxytocic Pharmaceuticals Sales Market Share by Application in 2020 & 2026
Figure 6. Abortion Induced Incomplete
Figure 7. Inevitable Abortion
Figure 8. Post-partum Haemorrhage
Figure 9. Labour Induction
Figure 10. Labour Arrest
Figure 11. Oxytocic Pharmaceuticals Report Years Considered
Figure 12. Global Oxytocic Pharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 13. Global Oxytocic Pharmaceuticals Sales 2015-2026 (K Pcs)
Figure 14. Global Oxytocic Pharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Oxytocic Pharmaceuticals Sales Market Share by Region (2015-2020)
Figure 16. Global Oxytocic Pharmaceuticals Sales Market Share by Region in 2019
Figure 17. Global Oxytocic Pharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 18. Global Oxytocic Pharmaceuticals Revenue Market Share by Region in 2019
Figure 19. Global Oxytocic Pharmaceuticals Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Oxytocic Pharmaceuticals Revenue in 2019
Figure 21. Oxytocic Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Oxytocic Pharmaceuticals Sales Market Share by Type (2015-2020)
Figure 23. Global Oxytocic Pharmaceuticals Sales Market Share by Type in 2019
Figure 24. Global Oxytocic Pharmaceuticals Revenue Market Share by Type (2015-2020)
Figure 25. Global Oxytocic Pharmaceuticals Revenue Market Share by Type in 2019
Figure 26. Global Oxytocic Pharmaceuticals Market Share by Price Range (2015-2020)
Figure 27. Global Oxytocic Pharmaceuticals Sales Market Share by Application (2015-2020)
Figure 28. Global Oxytocic Pharmaceuticals Sales Market Share by Application in 2019
Figure 29. Global Oxytocic Pharmaceuticals Revenue Market Share by Application (2015-2020)
Figure 30. Global Oxytocic Pharmaceuticals Revenue Market Share by Application in 2019
Figure 31. North America Oxytocic Pharmaceuticals Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Oxytocic Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Oxytocic Pharmaceuticals Sales Market Share by Country in 2019
Figure 34. North America Oxytocic Pharmaceuticals Revenue Market Share by Country in 2019
Figure 35. U.S. Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Oxytocic Pharmaceuticals Market Share by Type in 2019
Figure 40. North America Oxytocic Pharmaceuticals Market Share by Application in 2019
Figure 41. Europe Oxytocic Pharmaceuticals Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Oxytocic Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Oxytocic Pharmaceuticals Sales Market Share by Country in 2019
Figure 44. Europe Oxytocic Pharmaceuticals Revenue Market Share by Country in 2019
Figure 45. Germany Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Oxytocic Pharmaceuticals Market Share by Type in 2019
Figure 56. Europe Oxytocic Pharmaceuticals Market Share by Application in 2019
Figure 57. Asia Pacific Oxytocic Pharmaceuticals Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Oxytocic Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Oxytocic Pharmaceuticals Sales Market Share by Region in 2019
Figure 60. Asia Pacific Oxytocic Pharmaceuticals Revenue Market Share by Region in 2019
Figure 61. China Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Oxytocic Pharmaceuticals Market Share by Type in 2019
Figure 84. Asia Pacific Oxytocic Pharmaceuticals Market Share by Application in 2019
Figure 85. Latin America Oxytocic Pharmaceuticals Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Oxytocic Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Oxytocic Pharmaceuticals Sales Market Share by Country in 2019
Figure 88. Latin America Oxytocic Pharmaceuticals Revenue Market Share by Country in 2019
Figure 89. Mexico Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Oxytocic Pharmaceuticals Market Share by Type in 2019
Figure 96. Latin America Oxytocic Pharmaceuticals Market Share by Application in 2019
Figure 97. Middle East and Africa Oxytocic Pharmaceuticals Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Oxytocic Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Oxytocic Pharmaceuticals Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Oxytocic Pharmaceuticals Revenue Market Share by Country in 2019
Figure 101. Turkey Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Oxytocic Pharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Oxytocic Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Oxytocic Pharmaceuticals Market Share by Type in 2019
Figure 108. Middle East and Africa Oxytocic Pharmaceuticals Market Share by Application in 2019
Figure 109. North America Oxytocic Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Oxytocic Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Oxytocic Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Oxytocic Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Oxytocic Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Oxytocic Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Oxytocic Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Oxytocic Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Oxytocic Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Oxytocic Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
オキシトシン受容体拮抗薬の世界市場（～2026年） Market Analysis and Insights: Global Oxytocin Receptor Antagonists Market The global Oxytocin Receptor Antagonists market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Oxytocin Receptor Antagonists Scope and Market Size Oxy…- 化学療法誘発性貧血（CIA）の世界市場（～2026年） Anaemia is a frequent complication of malignancy and is aggravated by chemotherapy. The key factor contributing to the growth of the global chemotherapy induced anemia market is the increase in the occurrence of cancer and anemia among geriatric patients. Market Analysis and Insights: Global Chemoth…
- オピオイド誘発性便秘治療の世界市場（～2026年） There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over …
- オピオイド誘発性便秘（OIC）治療の世界市場（～2026年） Market Analysis and Insights: Global Opioid-Induced Constipation (OIC) Treatment Market The global Opioid-Induced Constipation (OIC) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Opioid-Induced Constipation…
- 化学療法薬誘発性肢端紅斑（手足症候群）治療の世界市場（～2026年） Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness) and desquamation (skin peeling) of palms, soles and rarely on knees and elbow. Acryl erythema is an adverse drug reaction which typically appear afte…